Catalog4 refs
Pinealon (EDR)
Nootropic & NeuroResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
cellstelomeresMitochondria
Overview
Synthetic tripeptide developed in Russia that penetrates nuclear membranes to directly interact with DNA, modulating gene expression via histone H1.3 binding and MAPK/ERK pathway activation. Benefits traumatic brain injury recovery and age-related cognitive decline with excellent safety profile. 40+ years of clinical use in Russia.
Primary Uses
Neuroprotection
Traumatic brain injury recovery
Cognitive enhancement
Memory enhancement
Anti-aging
Cellular senescence reduction
Biological age marker improvement
Protocol Reference
Dose
Injectable: 5mg daily or 100-300mcg daily; Oral: 0.2mg twice daily
Frequency
Injectable: daily for 20 days; Oral: morning and afternoon on empty stomach
Half-life
Not established
Route
Subcutaneous · Oral · Nasal
Evidence
Well Studied
Research Models
HumanMouseRat
Also in Nootropic & Neuro